THOMAS MCNERNEY & PARTNERS LP's Net Worth
-$13.9 Million
Who is THOMAS MCNERNEY & PARTNERS LP?
THOMAS MCNERNEY & PARTNERS LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CLARUS THERAPEUTICS INC, Coley Pharmaceutical Group, Inc., ZOGENIX, INC., Clarus Therapeutics Holdings, Inc., and TRANZYME INC.
SEC CIK
THOMAS MCNERNEY & PARTNERS LP's CIK is 0001231291
Past Insider Trading and Trends
2010 was THOMAS MCNERNEY & PARTNERS LP's most active year for acquiring shares with 4 total transactions. THOMAS MCNERNEY & PARTNERS LP's most active month to acquire stocks was the month of October. 2010 was THOMAS MCNERNEY & PARTNERS LP's most active year for disposing of shares, totalling 3 transactions. THOMAS MCNERNEY & PARTNERS LP's most active month to dispose stocks was the month of October. 2013 saw THOMAS MCNERNEY & PARTNERS LP paying a total of $10,054,062.00 for 1,675,677 shares, this is the most they've acquired in one year. In 2011 THOMAS MCNERNEY & PARTNERS LP cashed out on 14,725,374 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CLARUS THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -68.25% | -3.75M |
$2.53 | -$9,494,867.36 | 1.75M |
Apr 20
| |||
| No matching records found | |||||||||
Coley Pharmaceutical Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.42% | -1.00M |
—
|
—
| 2.41M |
May 18
| |||
Form 4
|
∞
| 2.78M |
—
|
—
| 2.78M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZOGENIX, INC. No price found
InvestorTHOMAS MCNERNEY & PARTNERS LP owns 1,663,193 units of Common Stock. In the year 2010 THOMAS MCNERNEY & PARTNERS LP filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.43M |
$4.00 |
—
| 1.43M |
Nov 29
| |||
Form 4
|
∞
| 1.73M |
$4.00 |
—
| 1.73M |
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clarus Therapeutics Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -68.25% | -3.75M |
$2.53 | -$9,494,867.36 | 1.75M |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TRANZYME INC No price found
InvestorTHOMAS MCNERNEY & PARTNERS LP owns 2,984,752 units of Common Stock and 1,675,677 units of Common Stock, par value $0.00001 per share.acquired a total of 4,574,266 shares in TRANZYME INC at a cost of $13,233,926.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
∞
| 2.44M |
$6.00 | $14,631,414.00 | 2.44M |
Feb 6 - Jul 15
| |||
Form 4
| +24.10% | 3M |
$4.00 | $3,250,000.00 | 15.46M |
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||